S&P 500   5,130.17 (+0.67%)
DOW   39,052.91 (+0.14%)
QQQ   445.18 (+1.41%)
AAPL   178.69 (-1.14%)
MSFT   414.93 (+0.31%)
META   501.98 (+2.42%)
GOOGL   138.16 (-0.22%)
AMZN   178.37 (+0.91%)
TSLA   204.33 (+1.21%)
NVDA   817.54 (+3.34%)
NIO   5.83 (+1.39%)
AMD   200.46 (+4.12%)
BABA   74.88 (+1.15%)
T   16.97 (+0.24%)
F   12.45 (+0.08%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.13 (+1.43%)
DIS   111.95 (+0.33%)
AMC   4.39 (+1.62%)
PFE   26.57 (+0.04%)
PYPL   60.64 (+0.50%)
XOM   105.87 (+1.29%)
S&P 500   5,130.17 (+0.67%)
DOW   39,052.91 (+0.14%)
QQQ   445.18 (+1.41%)
AAPL   178.69 (-1.14%)
MSFT   414.93 (+0.31%)
META   501.98 (+2.42%)
GOOGL   138.16 (-0.22%)
AMZN   178.37 (+0.91%)
TSLA   204.33 (+1.21%)
NVDA   817.54 (+3.34%)
NIO   5.83 (+1.39%)
AMD   200.46 (+4.12%)
BABA   74.88 (+1.15%)
T   16.97 (+0.24%)
F   12.45 (+0.08%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.13 (+1.43%)
DIS   111.95 (+0.33%)
AMC   4.39 (+1.62%)
PFE   26.57 (+0.04%)
PYPL   60.64 (+0.50%)
XOM   105.87 (+1.29%)
S&P 500   5,130.17 (+0.67%)
DOW   39,052.91 (+0.14%)
QQQ   445.18 (+1.41%)
AAPL   178.69 (-1.14%)
MSFT   414.93 (+0.31%)
META   501.98 (+2.42%)
GOOGL   138.16 (-0.22%)
AMZN   178.37 (+0.91%)
TSLA   204.33 (+1.21%)
NVDA   817.54 (+3.34%)
NIO   5.83 (+1.39%)
AMD   200.46 (+4.12%)
BABA   74.88 (+1.15%)
T   16.97 (+0.24%)
F   12.45 (+0.08%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.13 (+1.43%)
DIS   111.95 (+0.33%)
AMC   4.39 (+1.62%)
PFE   26.57 (+0.04%)
PYPL   60.64 (+0.50%)
XOM   105.87 (+1.29%)
S&P 500   5,130.17 (+0.67%)
DOW   39,052.91 (+0.14%)
QQQ   445.18 (+1.41%)
AAPL   178.69 (-1.14%)
MSFT   414.93 (+0.31%)
META   501.98 (+2.42%)
GOOGL   138.16 (-0.22%)
AMZN   178.37 (+0.91%)
TSLA   204.33 (+1.21%)
NVDA   817.54 (+3.34%)
NIO   5.83 (+1.39%)
AMD   200.46 (+4.12%)
BABA   74.88 (+1.15%)
T   16.97 (+0.24%)
F   12.45 (+0.08%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.13 (+1.43%)
DIS   111.95 (+0.33%)
AMC   4.39 (+1.62%)
PFE   26.57 (+0.04%)
PYPL   60.64 (+0.50%)
XOM   105.87 (+1.29%)

Alpine Immune Sciences (ALPN) Earnings Date, Estimates & Call Transcripts

$36.05
+0.83 (+2.36%)
(As of 01:33 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

ALPN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALPN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alpine Immune Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.41)($0.20)($0.32)
Q2 20243($0.44)($0.20)($0.34)
Q3 20243($0.46)($0.21)($0.36)
Q4 20243($0.47)($0.34)($0.41)
FY 202412($1.78)($0.95)($1.44)

ALPN Earnings Date and Information

Alpine Immune Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off prior year's report dates.

Alpine Immune Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/28/2024
Estimated)
------- 
11/14/2023Q3 2023($0.35)($0.24)+$0.11($0.24)$8.73 million$10.04 million
8/14/2023Q2 2023($0.38)($0.27)+$0.11($0.27)$8.08 million$8.59 million
5/11/2023Q1 2023($0.37)($0.28)+$0.09($0.28)$8.60 million$9.39 million
3/23/2023Q4 2022($0.27)($0.41)($0.14)($0.41)$10.42 million$2.78 million    
11/14/2022Q3 2022($0.10)($0.42)($0.32)($0.42)$20.43 million$8.37 million
8/11/2022Q2 2022($0.39)($0.60)($0.21)($0.60)$8.64 million$5.29 million
5/12/2022Q1 2022($0.17)($0.25)($0.08)($0.25)$13.35 million$13.63 million    
3/17/2022Q4 2021($0.26)($0.52)($0.26)($0.52)$8.26 million$4.53 million
11/9/2021Q3 2021$0.01($0.55)($0.56)($0.55)$22.30 million$8.52 million
8/9/2021Q2 2021($0.29)($0.46)($0.17)($0.46)$6.59 million$7.19 million    
5/12/2021Q1 2021($0.36)($0.45)($0.09)($0.45)$5.84 million$3.20 million  
3/17/2021Q4 2020($0.31)($0.27)+$0.04($0.27)$2.80 million$5.64 million  












Alpine Immune Sciences Earnings - Frequently Asked Questions

When is Alpine Immune Sciences's earnings date?

Alpine Immune Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off last year's report dates. Learn more on ALPN's earnings history.

How much revenue does Alpine Immune Sciences generate each year?

Alpine Immune Sciences (NASDAQ:ALPN) has a recorded annual revenue of $30.06 million.

How much profit does Alpine Immune Sciences generate each year?

Alpine Immune Sciences (NASDAQ:ALPN) has a recorded net income of -$57.76 million. ALPN has generated -$1.20 earnings per share over the last four quarters.

What is Alpine Immune Sciences's EPS forecast for next year?

Alpine Immune Sciences's earnings are expected to decrease from ($1.14) per share to ($1.46) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ALPN) was last updated on 3/1/2024 by MarketBeat.com Staff